Saturday 17 October 2026
Export INDP’s income statement to Excel — free account
Indaptus Therapeutics, Inc.
INDP Healthcare Biotechnology
In the quarter to June 2026, EPS grew 99.8% and free cash flow grew 52.0%, each against the same quarter a year earlier.
2.63
0.22
−7.72%
Follow INDP
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Current Ratio |
19.48 | 2.34 | 1.51 | 2.88 |
+8 more quarters Free account |
Net Debt/EBITDA |
6.39 | 0.69 | 1.04 | 2.20 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.07 | 2.76 | 0.39 | 0.86 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(0.02) | (0.64) | (3.30) | (2.58) | |
Cash per Share |
0.10 | 0.14 | 8.81 | 5.84 | |
Shareholders Equity per Share |
0.10 | 0.11 | 3.26 | 4.62 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.10 | 0.11 | 3.26 | 4.62 | |
Free Cash Flow |
(1.93) | (7.01) | (3.19) | (2.57) | |
Working Capital |
11.37 | 1.25 | 3.15 | 4.20 | |
Net Current Asset Value |
11.37 | 1.25 | 3.15 | 4.20 | |
| Other line items | |||||
Quick Ratio |
18.77 | 1.61 | 1.38 | 2.61 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.02) | (0.64) | (3.30) | (2.58) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Payables |
1.30 | 1.74 | 4.73 | 2.18 | |
Average Assets |
9.41 | 3.80 | 8.32 | 7.54 | |
Average Common Equity |
4.85 | 2.02 | 3.54 | 5.30 |
Columns are period end dates